Exact Sciences Announces Tufts Health Plan to Cover Cologuard®
Exact Sciences Corp. today announced that Tufts Health Plan, with more than 1 million members across Massachusetts and Rhode Island, will cover Cologuard as a colon cancer screening test effective March 15, 2015. Cologuard is the first and only FDA- approved, noninvasive stool-based DNA colorectal cancer screening test for average risk patients.
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News